The analgesic effect of Nebulized Morphine, Fentanyl Transdermal Patch and Oral Methadone

Phase 3

• Conditions: Condition 1: Breast cancer. Condition 2: Lung cancer. Condition 3: Prostate cancer. Condition 4: Liver cancer. Condition 5: Colon cancer. Condition 6: Stomach cancer. Condition 7: Uterus cancer. Condition 8: Bladder cancer.; Malignant neoplasm of breast; Malignant neoplasm of bronchus and lung; Malignant neoplasm of prostate; Liver cell carcinoma; Malignant neoplasm of colon; Malignant neoplasm of stomach; Malignant neoplasm of uterus, part unspecified; Malignant neoplasm of bladder

• Registration Number: IRCT20171211037834N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Suffering from moderate or severe pain
Patient awareness about his/her situation and illness
Suitable Glasgow Coma Scale (GCS) for patient cooperation

Exclusion Criteria

Allergy to Opioids
Hypotension(Systolic Blood pressure lower than 110 mmHg)
Bradypnea (respiration rate less than 12 times per minutes)
Hypoxemia (Oxygen saturation lower than 90 percent in room temperature)
Rhinitis
Liver and kidney disorders
Hypothyroidism
Prostate hypertrophy
Addison's disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: At the beginning of the study (before the intervention) and at the beginning and end of each day for 3 days. Method of measurement: Visual Analog Score that is numbered from 0 to 10.